uiring treatment Novo Nordisk ® Distribution of patients and value across treatment classes 100% 80% 60% 40% 20% 0% Insulin 44% 18% 4% 8% 26% Patients GLP-1 SGLT-2i 5% 17% 15% 22% 40% DPP-IV Value Traditional OADs cover: metformin, sulfonylurea, thiazolidinediones. Numbers do not add up to 100% due to rounding
Download PDF file